Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:03 PM
Ignite Modification Date:
2025-12-24 @ 11:03 PM
NCT ID:
NCT02489669
Eligibility Criteria:
Inclusion Criteria:
* All consecutive patients with chronic kidney disease (CKD) scheduled for coronary and/or peripheral angiography and/or angioplasty with an eGFR \<45 ml/min/1.73 m2 and/or
* At high risk for CI-AKI according to Mehran's score ≥11 and/or Gurm's score \>7
Exclusion Criteria:
* Age \<18 years
* Women who are pregnant
* Acute pulmonary edema
* Acute myocardial infarction
* Recent contrast media exposure
* End-stage CKD on chronic dialysis
* Multiple myeloma
* Current enrolment in any other study when enrolment in the REMEDIAL III would involve deviation from either protocol
* Cardiogenic shock
* Administration of theophilline, dopamine, mannitol and fenoldopam
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02489669
Study Brief:
Protocol Section:
NCT02489669